E
KNTE

Ergoteles’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Ergoteles’s Portfolio KNTE Stock Details KNTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-19,060
Closed -$215K – 2091
2022
Q1 		$215K Buy
+19,060
New +$215K 0.01% 964